HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -72.4% | 211 | -73.9% | 0.00% | – |
| Q2 2023 | $29 | +383.3% | 807 | +366.5% | 0.00% | – |
| Q1 2023 | $6 | -97.7% | 173 | -96.2% | 0.00% | -100.0% |
| Q4 2022 | $262 | -95.6% | 4,591 | +3133.1% | 0.00% | – |
| Q3 2022 | $6,000 | -53.8% | 142 | -57.0% | 0.00% | – |
| Q4 2021 | $13,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | -13.3% | 330 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | -53.1% | 330 | -56.6% | 0.00% | – |
| Q1 2021 | $32,000 | -15.8% | 760 | -15.6% | 0.00% | – |
| Q4 2020 | $38,000 | +11.8% | 900 | -30.8% | 0.00% | – |
| Q3 2020 | $34,000 | -37.0% | 1,300 | -35.0% | 0.00% | – |
| Q2 2020 | $54,000 | -85.6% | 2,000 | -89.6% | 0.00% | -100.0% |
| Q1 2018 | $376,000 | -3.1% | 19,172 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $388,000 | – | 19,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |